Form 10-Q ZIMMER BIOMET HOLDINGS, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities
November 4, 2021 6:09 PM EDTTruist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.
The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More
